In China, the scorpion Buthus martensii Karsch is used as functional food and medicinal materials. The scorpion, scorpion venoms and their extracts are effective in treating a variety of nervous system diseases such as epilepsy, apoplexy pains and facial paralysis. Apart from these therapeutic effects, the peptides purified from scorpions and their venom also showed antitumor activities, antimicrobial effects and protective effects on vascular. In this review, we reported various pharmacological effects of bioactive peptides purified from scorpion Buthus martensii Karsch so that we can use different effects of these bioactive peptides to treat different diseases and provide reference for the study of scorpion Buthus martensii Karsch in future.
Pharmacological activities of peptides
Antimicrobial activity Antimicrobial peptides (AMPs) are widely distributed in various species including plants, insects, humans, as well as single-celled organisms [8] . The structure of AMPs is usually amphiphilic topology [9, 10] . Recently, researchers have reported and identified some venom peptides from the scorpion BmK, which are found to show antimicrobial activity in vivo and in vitro. Some of these peptides present highly amphiphilic structure. Xian et al. [11] identified two amphiphilic venom peptides BmKb1 and BmKn2 from Buthus martensii Kasch. The functional tests showed that BmKn2 exhibited strong inhibitory activities against both Grampositive and Gram-negative bacteria while BmKb1 had weaker activity than BmKn2 in suppressing the growth of these bacteria [11] . Furthermore, BmKn2-7 ( Figure 1 ), a derivative of BmKn2 designed by Cao et al. [12] showed higher antibacterial activity against clinical antibiotic-resistant strains and increased inhibitory activity against both Gram-positive and Gram-negative bacteria. Additionally, the hemolytic activity of BmKn2-7 was distinctly decreased compared with BmKn2. Animal studies showed that the topical use of BmK2n-7 could protect the skin of mice which was infected by Staphylococcus aureus Gao et al. [13] isolated two compounds, 3β-acetoxyl,2,14,22-trihydroxy, 9-hydroxymethyl,9α,5β,14β-card-20(22)enoli (1; Figure 1 ) and 1,2,3,4-tetrahydro-6-hydroxy1-5-pyrimidinecarbox-aldehyde (2; Figure 1 ), from 70% methanol extracts of Chinese scorpion BmK by medium pressure liquid chromatography and RP-HPLC analysis technology. Both compounds exerted inhibitory activities against the Gram-positive bacteria Bacillus subtilis. And the minimum inhibitory concentration of the two compounds is 15 µg/ mL.
Antitumor activity
Gliomas cells can diffuse into the normal brain tissue. And Matrix metalloproteinase-2(MMP-2) and chloride ion channel play an important role in invasion of glioma cell [14, 15] . Recently, researchers found that Cltx, as a specific chloride channel blocker, could bind specifically to glioma cell surface and inhibit the glioma cell migration. The first chlorotoxin (Cltx)-like peptide, BmK CT, isolated from the venom gland of BmK [16] , is a novel blocker of the chloride ion channel and MMP-2 [17] . Yuejun Fu et al. [18] studied the influence of basic residues in BmK CT on the inhibitory activity to MMP-2 and proposed a model of BmK CT-MMP-2 catalytic domain complex to explain the relationship between the molecular structure of BmK CT and its mechanism in inhibition of glioma cell migration. Subsequently, Yuejun Fu et al. [19] found BmK CT expression was mediated by pEGFP-N1 and displayed a significant suppression in migration of rat glioma C6 cells by in vitro studies. Moreover, Yuejun Fu et al. [20] also performed a study to observe the combination of gene therapy pEGFP-N1-BmK CT with lithium chloride (LiCl) on C6 glioma cells. They reported that the combination therapy could inhibit the secretion and proliferation of pro-MMP2 in a synergistic manner, which might provide a new therapeutic strategy for glioma cancer. Besides, JianHua Shao et al. [21] isolated a dual-function peptide with analgesic and antitumor activities from scorpion venom. The peptide, BmK AGAP-SYPU2, showed antitumor effect in the Ehrlich ascites model and S-180 fibrosarcoma models in vivo.
Pharmacological property Active peptides References
BmKAS Cui et al. [35] Anti-epilepsy activity in vivo AEP Wang JH et al. [39] Zhang H et al. [40] Anti-vascular disease in vivo and vitro Martentoxin SVAP Gao SJ et al. [41] Wang JX et al. [44] 1 2 Whole scorpion, scorpion tails or their extracts are effective in soothing nerves and relieving pains caused by meningitis, cerebral palsy and rheumatism [22] . To date, more and more analgesic peptides from venom of the scorpion BmK have been found such as BmK IT2 [23] , BmK dITAP3 [24] , AngP1 [22] , BmK AGP-SYPU1 [25] [26] [27] , BmK AGP-SYPU2 [28] [29] [30] , BmK AGAP [31] [32] [33] [34] and BmKAS [35] . Moreover, Li et al. [36] reported that the venom of scorpion did not elicit dependence, while the analgesic substances such as morphine, heroin and aspirin have some side effects, in particular, the addictive nature of narcotic drugs. Therefore, the analgesic peptides from venom of scorpion BmK can be used as potential analgesic ingredients.
Depressant and excitatory insect neurotoxins: Scorpion neurotoxin can be divided into α-and β-toxins. Scorpion α-toxins are further divided into three different pharmacological subfamilies including classical α-mammal toxins, insect α-toxins, α-like toxins, which is according to their activities against mammals and insects [37] . In addition, neurotoxins also can be classified to depressant and excitatory toxins according to the symptomatology developed by injected animals [38] . BmK IT2 and BmK dITAP3 are depressant neurotoxins, which had been previously purified from venom of the scorpion BmK. The bioassay showed that both peptides could produce antinociception in rats and BmK dITAP3 exhibited 43% inhibition efficiency for analgesia at the dosage of 5mg/kg [23, 24] . AngP1, an excitatory insect neurotoxin, purified from scorpion BmK was reported to show 43% inhibition efficiency for analgesia at a dose of 5mg/kg on mice. And AngP1 was definitely devoid of mammalian toxicity [22] .
BmK AGP-SYPU1: Yu Wang et al. [25] initially purified the analgesic peptides named BmK AGP-SYPU1 from the venom of Chinese scorpion BmK through a four-step chromatographic process. The recombinant BmK AGP-SYPU1 was also isolated from soluble fractions in the E. coli cell lysate and purified with metal chelating affinity column and cation exchange chromatography. The mouse twisting assay indicated that the native and recombinant BmK AGP-SYPU1 showed similar analgesic effects on mice. Subsequently, Yu Wang et al. [26] further investigated the relationship between the arginines in the C-terminal (65-67) of BmK AGP-SYPU1 and the analgesic activity. They found the arginines in the C-terminal were crucial for the analgesic activity and might be located at analgesic functional sites. Besides, the study by Li Deng et al. [27] identified a new relationship between the structure and analgesic activity of the scorpion BmK AGP-SYPU1. They performed a study to investigate the role of two conversed tyrosines (Tyr5 and Tyr42) from BmK AGP-SYPU1. The mouse-twisting test showed that Tyr5 and Tyr42 were involved in the analgesic activity. And the results of molecular simulation revealed that the core domain of BmK AGP-SYPU1 ( Figure 2 ) was the key to analgesic activity and Tyr42 might be associated with pharmacological function when the core domain conformation was altered.
Antinociceptive activity
The mouse writhing test by Rong Zhang et al. showed that BmK AGP-SYPU1 inhibited 70% of the twisting action induced by acetic acid in mice at a dose of 0.1 mg/kg body weight [28] . BmK AGP-SYPU2: BmK AGP-SYPU2 is an analgesic peptide which is composed of 66 amino acid residues [28] . Rong Zhang et al. [28] purified BmK AGP-SYPU2 from the Chinese scorpion BmK through five continuous chromatographic steps. They identified the target peptides in every separation step by the mouse twisting model test and determined the molecular weight, isoelectric point and N-terminal sequence of the peptide. The mouse writhing test showed that BmK AGP-SYPU2 inhibited 64.3% of the twisting action induced by acetic acid in mice at a dose of 0.1 mg/kg body weight [28] . The functional role of glycines in the C-terminal end of BmK AGP-SYPU2 was investigated by Rong Zhang et al. [29] . They detected the analgesic activity of nature BmK AGP-SYPU2 and its mutants which were obtained by site-directed mutagenesis. When the glycines at the C-terminal end Volume 3 | Issue 2 AGAP: Antitumor-analgesic peptide (AGAP) has both analgesic and antitumor activity which was purified from the venom of the Chinese scorpion BmK. Yanfeng Liu et al. [31] reported the expression and purification of AGAP in Escherichia coli and demonstrated the analgesic and antitumor activities of AGAP on mice. Rui Ma et al. [32] looked for the analgesic domains by using the conformational stability, catalytic activity and folding, and site-directed mutagenesis in disulfide bridges and examined the analgesic activity of 12 mutants through the mouse-twisting assay. They found the key to the analgesic activity, which was called "core domain". In addition, Yong Cui et al. [33] studied the role of residues in AGAP by using an effective Escherichia coli expression system and site-directed mutagenesis. They evaluated the extent to which residues of AGAP contributed to its analgesic activity and pinpointed the important residue for the analgesic activity by replacing all of these residues individually with one amino acid.
Anti-epilepsy activity
Qinghong Mao et al. [34] investigated the antinociceptive effect and underlying mechanism of AGAP from scorpion BmK. AGAP were injected in doses of 0.2, 1 and 5 mg intraplantarly (i.pl.) at 10 min before formalin injection in mice. The number of flinching paw showed that formalin-induced inflammatory pain could be suppressed by pre-intraplantar injection of AGAP in a dose-dependent manner through a MAPKs-mediated mechanism in mice. Furthermore, AGAP could enhance the effects of the inhibitors of MAPKs on the inflammatory pain.
Anti-vascular disease altered, the analgesic activity of mutant was significantly decreased. The study indicated that glycines at the C-terminal end played an important role for the analgesic activity of BmK AGP-SYPU2. Subsequently, Yongshan Zhao et al. [30] further investigated the relationship between the C-terminal segment of BmK AGP-SYPU2 and their analgesic activity by performing three molecular dynamics simulations (BmK AGP-SYPU2 structure and its two mutants of its structure). The data of these calculations suggested that the glycine residues at the C-terminal segment stabilized the protruding topology of the NC domain, which was an important decisive factor for the analgesic activity of BmK AGP-SYPU2.
In China, scorpions have been used to treat epilepsy and convulsion by Chinese traditional doctors since the Sung Dynasty (A.D. 960-1279) [39] .
The first anti-epilepsy peptide (AEP) was isolated and purified from venom of scorpion BmK by Zhou et al. [1] . The peptide is composed of 66 residues from 18 amino acids and has molecular weight of 8290. The pharmacological test suggested that AEP could suppress epilepsy induced by coriaria lactone and cephaloridine and had no side effect on heart rate and blood pressure in rats even after the dose reached 28 mg/kg body weight. Chunguang Wang et al. [40] further confirmed its anti-epilepsy effect on rat. They found BmK AEP showed anti-epilepsy activity when at the dose of 0.057 µg•g -1 body weight. Chunguang Wang et al. [40] also found the toxicity of BmK AEP in mammalian and insects was very weak even the dosage of BmK AEP was up to 20 µg and 2 µg, respectively. While the typical mammalian toxins, such as BmK M1 and the excitatory insect toxin BmK IT-AP could cause paralysis. The cDNA sequence of BmK AEP showed that it shared homology with other depressant insect toxins, but there was a remarkable difference between them mainly focused at residues 6, 7 and 39, which might relate to the unique action of BmK AEP.
In certain vascular disease, nitric oxide (NO) can be released from the endothelium, which is one of the most important vasoactive substances [41] . NO is produced by nitric oxide synthase (NOS) which includes neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) in mammals [42, 43] .
NO release in endothelium is associated with Hyperpolarization which is caused by the activation of Ca 2+ -activated K + channels (BKCa channels) Jun Wang et al. [41] purified a large-conductance Ca 2+ -activated K + channel inhibitor, martentoxin, from BmK and demonstrated its protective effects in inflammatory vascular diseases. They found martentoxin decreased NO production and iNOS activation induced by TNF-α. They also demonstrated that martentoxin retarded the down-regulation of eNOS mRNA induced by TNF-α in human umbilical vein endothelial cells (HUVECs).
Yimin Song et al. [44] performed studies to investigate effects of scorpion venom active polypeptide (SVAP) from scorpion BmK on platelet aggregation in ex vivo and vitro in rabbits, thrombosis in carotid artery of rats as well as plasma 6-keto-PG F 1α and TXB 2 in rats. The results showed that SVAP significantly inhibited the rabbit platelet aggregation triggered by thrombin and ADP in vitro and at the dose of 0.32, 0.64 mg/kg iv extended the occlusion time of thrombosis induced by electrical stimulation. Additionally, SVAP could distinctly increase the plasma concentration of 6-keto-PG F 1α and value of PG I 2 /TXA 2 , but slightly affect rats plasma concentration of TXB 2 in vitro and in ex vivo, which indicated the mechanism of the antithrombotic action of SVAP.
Other beneficial effects
There are not only these pharmacological effects of BmK described above, but also other beneficial effects. As is well known, scorpion and its venom have been used in Traditional Chinese Medicine to treat chronic neurological disorders. The mechanism about that was studied. Tao Wang et al. [45] purified scorpion venom heat-resistant peptide (SVHRP) from scorpion BmK, confirmed its neurotrophic effect in vitro and in vivo and explored associated molecular mechanisms. They found the concentrations of BDNF, NGF and GDNF were higher in the conditioned medium of SVHRP-pretreated astrocytes, in contrast to normal astrocyteconditioned medium. And more GFAP-positive cells were detected in SVHRP treated mouse brain. Furthermore, BmKbpp, a 47
Scorpion Buthus martensii Karsch are rich in peptides which represent a tremendous unexplored resource for use in drug design and development. For now, more and more researchers study the role of amino acids in pharmacological activities and characterize the structure-function relationships of bioactive peptides in order to design the peptides with higher bioactivity by using sitedirected mutagenesis and gene cloning technology. Based on the identified peptides purified from scorpion Buthus martensii Karsch, some researchers have tried to establish a new, economical and effective system for industrial peptides production with the use of molecular cloning technique [48] . However, some bioactivity peptides have not been identified and the mechanism of some pharmacological effects is not clarified. Furthermore, though the scorpion has been traditionally used as a source of drugs, the clinical studies about single peptide are few. Careful clinical studies comparing pharmacological activities of the whole scorpion, scorpion venom, the extracts of them and the single peptides still need to determine whether the single peptides of scorpion Buthus martensii Karsch provide real clinical benefits.
amino acid peptide, was demonstrated that it acted as a signaling molecule involving innate immune regulation at low concentrations and displayed bradykinin potentiating and immune-modulatory activities [46] . As described above, the peptides SVAP purified from scorpion BmK have effects of inhibiting the rabbit platelet aggregation and thrombosis. One study indicated that SVAP also could improve mesenteric microcirculation [47] .
Conclusion

